Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by introduction of biosimilars, increasing incidence of chronic diseases and immunological disorders, and patent expiry of major biologics.
The biologic therapeutics market is segmented as below:
By Application
- Cancer
- Infectious diseases
- Autoimmune diseases
- Others
By Product
- Antibody therapeutics
- Vaccines
- Cell therapy
- Gene therapy
- Others
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the biologic therapeutics market covers the following areas:
- Biologic therapeutics market sizing
- Biologic therapeutics market forecast
- Biologic therapeutics market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
Executive Summary
The following companies are recognized as the key players in the global biologic therapeutics market: AbbVie Inc., Amgen Inc., Apogenix AG, AstraZeneca Plc, Aurobindo Pharma Ltd., Baxter International Inc., Biocon Ltd., BioMarin Pharmaceutical Inc., Celltrion Healthcare Co. Ltd., Eli Lilly and Co., GangaGen Biotechnologies Pvt Ltd., GlaxoSmithKline Plc, Johnson and Johnson Services Inc., Merck and Co. Inc., Novartis AG, Pfizer Inc., Precision Biologics Inc., Samsung Electronics Co. Ltd., Sanofi SA, and Tubulis GmbH.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is strong research and development pipeline."
According to the report, one of the major drivers for this market is the introduction of biosimilars.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie Inc.
- Amgen Inc.
- Apogenix AG
- AstraZeneca Plc
- Aurobindo Pharma Ltd.
- Baxter International Inc.
- Biocon Ltd.
- BioMarin Pharmaceutical Inc.
- Celltrion Healthcare Co. Ltd.
- Eli Lilly and Co.
- GangaGen Biotechnologies Pvt Ltd.
- GlaxoSmithKline Plc
- Johnson and Johnson Services Inc.
- Merck and Co. Inc.
- Novartis AG
- Pfizer Inc.
- Precision Biologics Inc.
- Samsung Electronics Co. Ltd.
- Sanofi SA
- Tubulis GmbH